| Literature DB >> 29658302 |
Pablo López1, Omayra De Jesús1, Yasuhiro Yamamura1, Nayra Rodríguez1, Andrea Arias1, Raphael Sánchez1, Yadira Rodríguez1, Vivian Tamayo-Agrait2, Wilfredo Cuevas3, Vanessa Rivera-Amill1.
Abstract
HIV-1 subtype B virus is the most prevalent subtype in Puerto Rico (PR), accounting for about 90% of infection in the island. Recently, other subtypes and circulating recombinant forms (CRFs), including F(12_BF), A (01_BF), and CRF-39 BF-like, have been identified. The purpose of this study is to assess the distribution of drug resistance mutations and subtypes in PR. A total of 846 nucleotide sequences from the period comprising 2013 through 2017 were obtained from our "HIV Genotyping" test file. Phylogenetic and molecular epidemiology analyses were performed to evaluate the evolutionary dynamics and prevalence of drug resistance mutations. According to our results, we detected a decrease in the prevalence of protease inhibitor, nucleoside reverse transcriptase inhibitor (NRTI), and non-NRTI (NNRTI) resistance mutations over time. In addition, we also detected recombinant forms and, for the first time, identified subtypes C, D, and CRF-24BG in PR. Recent studies suggest that non-subtypes B are associated with a high risk of treatment failure and disease progression. The constant monitoring of viral evolution and drug resistance mutation dynamics is important to establish appropriate efforts for controlling viral expansion.Entities:
Keywords: HIV-1; HIV-1 subtypes; drug resistance mutations
Mesh:
Year: 2018 PMID: 29658302 PMCID: PMC5994676 DOI: 10.1089/AID.2017.0305
Source DB: PubMed Journal: AIDS Res Hum Retroviruses ISSN: 0889-2229 Impact factor: 2.205